{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:18:29Z","timestamp":1793121509476,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.cca.2022.12.014","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T20:04:42Z","timestamp":1671480282000},"page":"203-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Serum metabolomics-based heterogeneities and screening strategy for metabolic dysfunction-associated fatty liver disease (MAFLD)"],"prefix":"10.1016","volume":"538","author":[{"given":"Li","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cca.2022.12.014_b0005","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International consensus, MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cca.2022.12.014_b0010","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hep. Intl."},{"issue":"1","key":"10.1016\/j.cca.2022.12.014_b0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"issue":"19","key":"10.1016\/j.cca.2022.12.014_b0020","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/CM9.0000000000000981","article-title":"From NAFLD to MAFLD: a \u201credefining\u201d moment for fatty liver disease","volume":"133","author":"Zheng","year":"2020","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"1","key":"10.1016\/j.cca.2022.12.014_b0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep4.1606","article-title":"Effects of cirrhosis and diagnosis scenario in metabolic-associated fatty liver disease-related hepatocellular carcinoma","volume":"5","author":"Chen","year":"2021","journal-title":"Hepatol. Commun."},{"issue":"24","key":"10.1016\/j.cca.2022.12.014_b0030","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1097\/CM9.0000000000001888","article-title":"Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma","volume":"134","author":"Rios","year":"2021","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"6","key":"10.1016\/j.cca.2022.12.014_b0035","doi-asserted-by":"crossref","first-page":"857","DOI":"10.21037\/hbsn-21-431","article-title":"The uprising of metabolic dysfunction-associated fatty liver disease (MAFLD) in acute-on-chronic liver failure (ACLF)","volume":"10","author":"Zheng","year":"2021","journal-title":"Hepatobil. Surg. Nutr."},{"issue":"5","key":"10.1016\/j.cca.2022.12.014_b0040","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.3390\/ijms22052350","article-title":"Treatments for NAFLD: state of art","volume":"22","author":"Mantovani","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cca.2022.12.014_b0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11306-021-01810-6","article-title":"Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype","volume":"17","author":"Mazzini","year":"2021","journal-title":"Metabolomics"},{"issue":"14","key":"10.1016\/j.cca.2022.12.014_b0050","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1042\/CS20210198","article-title":"Glycoursodeoxycholic acid ameliorates diet-induced metabolic disorders with inhibiting endoplasmic reticulum stress","volume":"135","author":"Cheng","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"issue":"17","key":"10.1016\/j.cca.2022.12.014_b0055","doi-asserted-by":"crossref","first-page":"9548","DOI":"10.3390\/ijms22179548","article-title":"The serum metabolome of moderate and severe COVID-19 patients reflects possible liver alterations involving carbon and nitrogen metabolism","volume":"22","author":"Caterino","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cca.2022.12.014_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107852","article-title":"Altered plasma serine and 1-deoxydihydroceramide profiles are associated with diabetic neuropathy in type 2 diabetes and obesity","volume":"35","author":"Fridman","year":"2021","journal-title":"J. Diabetes Compl."},{"issue":"3","key":"10.1016\/j.cca.2022.12.014_b0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/metabo11030188","article-title":"Stable isotopic tracer phospholipidomics reveals contributions of key phospholipid biosynthetic pathways to low hepatocyte phosphatidylcholine to phosphatidylethanolamine ratio induced by free fatty acids","volume":"11","author":"Peng","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.cca.2022.12.014_b0070","doi-asserted-by":"crossref","first-page":"8813410","DOI":"10.1155\/2021\/8813410","article-title":"Metabolic alteration in hepatocellular carcinoma: mechanism of lipid accumulation in well-differentiated hepatocellular carcinoma","volume":"2021","author":"Suzuki","year":"2021","journal-title":"Can. J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.cca.2022.12.014_b0075","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic steatohepatitis clinical research, design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cca.2022.12.014_b0080","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.cca.2022.12.014_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110271","article-title":"Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19","volume":"38","author":"Bi","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.cca.2022.12.014_b0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41421-021-00361-3","article-title":"Cross-species metabolomic analysis identifies uridine as a potent regeneration promoting factor","volume":"8","author":"Liu","year":"2022","journal-title":"Cell Disc."},{"issue":"1","key":"10.1016\/j.cca.2022.12.014_b0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","article-title":"Proteomic and metabolomic characterization of COVID-19 patient sera","volume":"182","author":"Shen","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cca.2022.12.014_b0100","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.gastro.2022.06.069","article-title":"Integrated analysis of colorectal cancer reveals cross-cohort gut microbial signatures and associated serum metabolites","volume":"163","author":"Gao","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2022.12.014_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.122073","article-title":"New insights into the Argan oil categories characterization: chemical descriptors, FTIR fingerprints, and chemometric approaches","volume":"225","author":"Kharbach","year":"2021","journal-title":"Talanta"},{"key":"10.1016\/j.cca.2022.12.014_b0110","article-title":"Microbiome-specific statistical modeling identifies interplay between gastrointestinal microbiome and neurobehavioral outcomes in patients with autism: a case control study","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Psych."},{"issue":"11","key":"10.1016\/j.cca.2022.12.014_b0115","doi-asserted-by":"crossref","first-page":"e1009442","DOI":"10.1371\/journal.pcbi.1009442","article-title":"Multivariable association discovery in population-scale meta-omics studies","volume":"17","author":"Mallick","year":"2021","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"10.1016\/j.cca.2022.12.014_b0120","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1002\/cpbi.86","article-title":"Using MetaboAnalyst 4.0 for comprehensive and integrative metabolomics data analysis","volume":"68","author":"Chong","year":"2019","journal-title":"Curr. Protoc. Bioinform."},{"issue":"1","key":"10.1016\/j.cca.2022.12.014_b0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis","volume":"52","author":"Rolo","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.cca.2022.12.014_b0130","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.cca.2022.12.014_b0135","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"issue":"5\u20136","key":"10.1016\/j.cca.2022.12.014_b0140","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.mam.2004.06.002","article-title":"Carnitine acyltransferases and their influence on CoA pools in health and disease","volume":"25","author":"Ramsay","year":"2004","journal-title":"Mol. Aspects Med."},{"issue":"6","key":"10.1016\/j.cca.2022.12.014_b0145","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3945\/jn.108.103754","article-title":"Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women","volume":"139","author":"Adams","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.cca.2022.12.014_b0150","doi-asserted-by":"crossref","unstructured":"P. Middleton, N. Vergis, Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulation, Therap. Adv. Gastroenterol. 14 (2021) 17562848211031394.","DOI":"10.1177\/17562848211031394"},{"issue":"9","key":"10.1016\/j.cca.2022.12.014_b0155","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/liv.12541","article-title":"Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC\/MS and UPLC\/MS-MS","volume":"34","author":"Fitian","year":"2014","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.cca.2022.12.014_b0160","doi-asserted-by":"crossref","first-page":"H794","DOI":"10.1111\/1750-3841.13210","article-title":"Effects of long-chain and medium-chain fatty acids on apoptosis and oxidative stress in human liver cells with steatosis","volume":"81","author":"Wang","year":"2016","journal-title":"J. Food Sci."},{"issue":"6","key":"10.1016\/j.cca.2022.12.014_b0165","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jdiacomp.2016.04.019","article-title":"Polyol accumulation in muscle and liver in a mouse model of type 2 diabetes","volume":"30","author":"Gallagher","year":"2016","journal-title":"J. Diabetes Compl."},{"issue":"7","key":"10.1016\/j.cca.2022.12.014_b0170","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/gut.2007.147496","article-title":"Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury","volume":"57","author":"Serviddio","year":"2008","journal-title":"Gut"},{"issue":"Pt 6","key":"10.1016\/j.cca.2022.12.014_b0175","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1042\/bst0311300","article-title":"Mitochondrial matrix reactive oxygen species production is very sensitive to mild uncoupling","volume":"31","author":"Miwa","year":"2003","journal-title":"Biochem. Soc. Trans."},{"issue":"11","key":"10.1016\/j.cca.2022.12.014_b0180","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1177\/153537020222701107","article-title":"The role of histidine in the anemia of folate deficiency","volume":"227","author":"Cooperman","year":"2002","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"3","key":"10.1016\/j.cca.2022.12.014_b0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/biof.1154","article-title":"Novel insights on interactions between folate and lipid metabolism","volume":"40","author":"da Silva","year":"2014","journal-title":"Biofactors"},{"issue":"11","key":"10.1016\/j.cca.2022.12.014_b0190","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.3390\/molecules26113377","article-title":"Vitamin K2 as a new modulator of the ceramide de novo synthesis pathway","volume":"26","author":"Kolakowski","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.cca.2022.12.014_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153559","article-title":"Neonatal streptozotocin treatment rapidly causes different subtype of hepatocellular carcinoma without persistent hyperglycemia in 4CS mice fed on a normal diet","volume":"225","author":"Kobayashi","year":"2021","journal-title":"Pathol. Res. Pract."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122014164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122014164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:09:36Z","timestamp":1757862576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898122014164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":39,"alternative-id":["S0009898122014164"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2022.12.014","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum metabolomics-based heterogeneities and screening strategy for metabolic dysfunction-associated fatty liver disease (MAFLD)","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2022.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}